|
IL277560D0
|
|
Methods for expanding adherent stromal cells and cells obtained thereby
|
|
IL274697A
|
|
Methods and compositions for treating viral infections and sequelae thereof
|
|
WO2020222233A1
|
|
Methods and compositions for producing cannabinoids
|
|
WO2020194307A1
|
|
Methods and compositions for aesthetic and cosmetic treatment and stimulating hair growth
|
|
WO2020095230A1
|
|
Therapeutic methods and compositions
|
|
WO2020070688A1
|
|
Modular bioreactor
|
|
WO2020044133A1
|
|
Methods and compositions for treating subjects exposed to vesicants and other chemical agents
|
|
WO2019239295A1
|
|
Therapeutic dosage regimens comprising adherent stromal cells
|
|
US2021115395A1
|
|
Methods for expanding adherent stromal cells and cells obtained thereby
|
|
WO2019021158A1
|
|
Methods and compositions for treating addictions
|
|
IL260253D0
|
|
Methods and compositions for detaching adherent cells
|
|
US2020246386A1
|
|
Methods and compositions for treating neurological disorders
|
|
IL258738D0
|
|
Methods and compositions for formulating and dispensing pharmaceutical formulations
|
|
WO2018185584A1
|
|
Methods and compositions for treating acute lung injury and respiratory distress syndrome
|
|
US2020080147A1
|
|
Methods and compositions for tumor assessment
|
|
US2018008649A1
|
|
Adherent stromal cells derived from placentas of multiple donors and uses thereof
|
|
IL251201D0
|
|
Methods and compositions for treating subjects exposed to vesicants and other chemical agents
|
|
AU2017220148A1
|
|
Methods and compositions for treating cancers and neoplasms
|
|
WO2017212309A1
|
|
Altered adherent stromal cells and methods of producing and using same
|
|
US2018015125A1
|
|
Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof
|
